FindMyKOL

Jeffrey Saver, MD

Enriched profile

Carol and James Collins Distinguished Professor of Neurology, David Geffen School of Medicine at UCLA · University of California, Los Angeles

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyNeurologyFocusStroke
Active KOLFindMyKOL type: EliteLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH funding1997–2026Why? →

Jeffrey Saver is Carol and James Collins Distinguished Professor of Neurology, David Geffen School of Medicine at UCLA at University of California, Los Angeles. ClinicalTrials.gov lists 15 registered studies with this person as an investigator.

Data verified 9 Oct 2026

Overview

Updated 25 Oct 2026

Jeffrey Saver, MD, is Carol and James Collins Distinguished Professor of Neurology, David Geffen School of Medicine at UCLA at University of California, Los Angeles (David Geffen School of Medicine at UCLA). The public record shows 5 publications with 1,426 citations (h-index 5), centered on Stroke. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 18 companies, 9 NIH-funded awards (1997–2026).

  • Top research focus: Stroke
  • 15 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 18 companies

Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Stroke15 trials

Research focus

OpenAlex concept fingerprint
Stroke

Drugs & molecules

across trials, industry payments and publications
Repathageneric · EvolocumabClinical trials—Industry payments4Publications—Tnkasegeneric · TenecteplaseClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trials—Industry payments29Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments22Abbott LaboratoriesClinical trials—Industry payments12CSL BehringClinical trials—Industry payments9Rapid Medical LtdClinical trials—Industry payments6Janssen Scientific Affairs, LLCClinical trials—Industry payments5Amgen Inc.Clinical trials—Industry payments4Philips North America LLCClinical trials—Industry payments3AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Biogen, Inc.Clinical trials—Industry payments2BrainQ Technologies Ltd.Clinical trials2Industry payments—Medtronic Neurovascular Clinical AffairsClinical trials2Industry payments—MIVI Neuroscience, Inc.Clinical trials—Industry payments2Philips Electronics North America CorporationClinical trials—Industry payments2University of Southern CaliforniaClinical trials2Industry payments—Xinqiao Hospital of ChongqingClinical trials2Industry payments—Abbott Medical DevicesClinical trials1Industry payments—Argenx Us, Inc.Clinical trials—Industry payments1Diffusion Pharmaceuticals IncClinical trials1Industry payments—F. Hoffmann-La Roche AGClinical trials—Industry payments1Genentech, Inc.Clinical trials—Industry payments1Grifols Therapeutics LLCClinical trials1Industry payments—Jeffrey L. SaverClinical trials1Industry payments—Occlutech Us LLCClinical trials—Industry payments1Rapid MedicalClinical trials1Industry payments—Roche Products LimitedClinical trials—Industry payments1Shionogi IncClinical trials—Industry payments1University of California, Los AngelesClinical trials1Industry payments—University of CincinnatiClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15clinical trials

Investigator role on registered studies.

View trials ↓
18companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
9NIH grants · 1997–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 25 Oct 2026

Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 25 Oct 2026

18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.7%
    PCSK9 Inhibitor27.9%
    Praluent Pen54%Repatha Sureclick46%
    Part D<11 patients
    Statin26.7%
    Rosuvastatin Calcium52%Atorvastatin Calcium48%
    Part D<11 patients
  • Blood & clotting

    45.3%
    Phosphodiesterase 3 Inhibitor25.6%
    Cilostazol100%
    Part D<11 patients
    P2Y12 inhibitor19.8%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)72% facility · 28% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 25 Oct 2026

9 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 25 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jeffrey-saver-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    berryconsultants.com/resource/37-a-visit-with-stroke-neurologist-dr-jeff-saver

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →berryconsultants.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 25 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Harvard Medical School

    1986
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • AB

    Harvard College (1981), Biochemical Sciences and Philosophy

    1981
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Editorial & leadership roles

journal and society appointments
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newsroom.ucla.edu ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Member

    Stroke Advisory Committee, American Heart Association

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsroom.ucla.edu ↗
  • Member

    Stroke Scientific Statement Oversight Committee, American Heart Association

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsroom.ucla.edu ↗
  • Honorary Fellow

    European Stroke Organization

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    UCLA Comprehensive Stroke Center

    1995
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsroom.ucla.edu ↗
  • Director

    UCLA NeuroTranslational Research Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.